Cancer Prevention & Control Prgm
癌症预防
基本信息
- 批准号:9365095
- 负责人:
- 金额:$ 6.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAreaBehavioralCancer Center Support GrantCancer ControlCancer PatientClinical TrialsCollaborationsCommunicationCommunitiesDecision MakingDiagnosisEarly DiagnosisEconomicsEnrollmentEnvironmental Risk FactorEpidemiologistFundingFunding AgencyHealth ServicesIndividualInformaticsInstructionLife ExperienceMalignant NeoplasmsMedicalMedical IndigencyNursesOncologistOrganizational PolicyOutcomePalliative CarePaperPatientsPeer ReviewPopulationPrimary Care PhysicianPsychologyPublicationsPublishingResearchResearch PersonnelResource SharingScientistServicesSpecialistTobacco Use CessationUnited States National Institutes of Healthanticancer researchbasebehavior changebehavior measurementbehavioral studyburden of illnesscancer carecancer health disparitycancer preventioncancer riskclinical practicehealthy lifestyleholistic approachinnovationmemberprogramssocialsocial groupsocioeconomicssociology/anthropologysurvivorshipunderserved minority
项目摘要
Since its establishment as a recognized program in 2001, the Cancer Prevention and Control (CPC) program
has matured into a highly interactive group that brings together scientists from across the entire VCU
academic community. The CPC program has a research funding base of over $8.3 million dollars in annual
direct support, of which more than $7.3 million is from the NIH or other peer-reviewed funding sources. Since
the last review period three years ago, research from the CPC program produced 259 publications, of which
26% represented intra-programmatic collaborations, 7% represented inter-programmatic collaborations, and
2% represented both intra and inter programmatic collaborations. More specifically, in 2010, the number of
intra programmatic collaborations sharply increased to 42%. In addition to these collaborations, 35 papers
(14%), 15 of which were published in 2010 (17%), were co-authored by clinician and social scientist
members of the CPC program.
The program is committed to transdisciplinary research and brings together a diverse group of social and
behavioral scientists from psychology, sociology, anthropology, health services, and economics with
clinicians (oncologists, primary care physicians, palliative care specialists, and nurses), biostatisticians,
epidemiologists, and geneticists to comprehensively explore fundamental and applied questions in cancer
prevention and control. The CPC program has four major areas of scientific emphasis. The first area of
research concentration seeks to understand the socioeconomic and cultural forces causing or contributing to
disparities in cancer outcomes with a focus on both underserved minority populations and communities, and
the medically indigent. Second, enhancement of cancer care outcomes through survivorship is concerned
with the lived experiences of patients diagnosed with cancer. The third focuses on the cancer prevention and
early detection through behavior change, healthy lifestyles, and tobacco cessation. The fourth emphasis
area of the CPC program is developing an innovative line of research that enhances treatment delivery,
cancer outcomes, and clinical trial enrollment by integrating communication and medical decision making
research into clinical practice. Program members have also developed shared resources, including the
Cancer Research Informatics and Services (CRIS) shared resource and the Behavioral Measurement
Shared Resource (BeMSR).
自2001年成立为公认的计划以来,癌症预防与控制(CPC)计划
已经成熟成一个高度互动的群体,该群体将来自整个VCU的科学家汇集在一起
学术界。 CPC计划的研究基础超过830万美元
直接支持,其中超过730万美元来自NIH或其他经过同行评审的资金来源。自从
三年前的最后一个审查期,CPC计划的研究生产了259个出版物,其中
26%代表截面内部合作,7%代表策略间的合作,并且
2%代表Intra Intra和Inter编程合作。更具体地说,在2010年,
程序内合作急剧增加到42%。除了这些合作,还有35篇论文
(14%),其中15个于2010年出版(17%),由临床医生和社会科学家合着
CPC计划的成员。
该计划致力于跨学科研究,并汇集了各种各样的社会和
心理学,社会学,人类学,卫生服务和经济学的行为科学家与
临床医生(肿瘤学家,初级保健医生,姑息治疗专家和护士),生物统计学家,
流行病学家和遗传学家全面探索癌症的基本问题和应用问题
预防和控制。 CPC计划具有四个主要的科学重点领域。第一个区域
研究集中力量旨在了解引起或促成的社会经济和文化力量
癌症结局的差异,重点是服务不足的少数群体和社区,以及
医学上的贫困。其次,涉及生存的增强癌症护理结果
随着被诊断出患有癌症的患者的生活经历。第三个侧重于预防癌症和
通过行为改变,健康的生活方式和烟草戒烟来提早发现。第四强调
CPC计划的领域正在开发一项创新的研究线,以增强治疗的交付,
通过整合沟通和医疗决策,癌症结果和临床试验入学
研究临床实践。计划成员还开发了共享资源,包括
癌症研究信息学和服务(CRIS)共享资源和行为衡量
共享资源(BEMSR)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GORDON D GINDER其他文献
GORDON D GINDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GORDON D GINDER', 18)}}的其他基金
The role of the MBD2-NuRD complex in gamma-globin gene silencing
MBD2-NuRD 复合物在 γ-珠蛋白基因沉默中的作用
- 批准号:
10208866 - 财政年份:2018
- 资助金额:
$ 6.25万 - 项目类别:
The role of the MBD2-NuRD complex in gamma-globin gene silencing
MBD2-NuRD 复合物在 γ-珠蛋白基因沉默中的作用
- 批准号:
10442549 - 财政年份:2018
- 资助金额:
$ 6.25万 - 项目类别:
The role of the MBD2-NuRD complex in gamma-globin gene silencing
MBD2-NuRD 复合物在 γ-珠蛋白基因沉默中的作用
- 批准号:
9976500 - 财政年份:2018
- 资助金额:
$ 6.25万 - 项目类别:
Globin Gene Expression during Erythroid Differentiation
红系分化过程中的球蛋白基因表达
- 批准号:
7901949 - 财政年份:2009
- 资助金额:
$ 6.25万 - 项目类别:
相似国自然基金
农产品出口区域化管理对企业和农户的行为决策及经济绩效影响研究
- 批准号:72373067
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
区域压缩对非线性噪声驱动的随机偏微分方程动力学行为影响的研究
- 批准号:12371178
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
长三角地区氯化石蜡的土壤—大气界面交换行为及区域环境影响研究
- 批准号:42307512
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
面向廊道式TOD(C-TOD)的巨型城市区域轨道交通对居民出行行为时空特征的影响机制研究
- 批准号:42201210
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
城市大型医院周边区域公共服务设施布局及其使用者行为和满意度的影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 6.25万 - 项目类别:
mPFC Regulation of VTA Dopamine and GABA Neuronal Activity During Flexible Updating of Appetitive and Aversive Associations
mPFC 在灵活更新食欲和厌恶关联过程中对 VTA 多巴胺和 GABA 神经元活动的调节
- 批准号:
10748174 - 财政年份:2024
- 资助金额:
$ 6.25万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 6.25万 - 项目类别: